Keeping An Eye On Metabolix

We were about to end the Street Fight segment on CNBC's Fast Money last night when the question rolled around to what a born skeptic like me likes.

Well, I don't RECOMMEND anything, but I said one stock of interest I have mentioned in the past is Metabolix (MBLX), a biotech company that makes biodegradable plastics out of corn, switch grass and other crops. I pointed out that it has joint-ventured with Archer-Daniels-Midland (ADM), a pre-IPO investor that bought more on the deal. (I actually wrote about this long before it went public and have kept an eye on it since.)

I also pointed out that like most developing biotechs, Metabolix is losing gobs of money, and still hasn't commercialized its product -- all of which makes it speculative.

Host Dylan Ratigan and panelist Eric Bolling tried to mock the idea ("he likes speculative money loser, blah, blah, blah.") Bolling went so far as to call it "alternative energy." Sorry, Charlie, er Eric, not even close. All of that said: It's interesting and generally under-the-radar, which is as likely to catch my attention as much as one that is not interesting and over-hyped.